Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma

MLA

Graeme O’Keefe, et al. “Phase I Trial of 131I-HuA33 in Patients with Advanced Colorectal Carcinoma.” Clinical Cancer Research, vol. 11, July 2005, pp. 4818–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....279d631fcd4731315833a01d22277f48&authtype=sso&custid=ns315887.

APA

Graeme O’Keefe, Niall C. Tebbutt, T. Saunder, Bridget Chappell, Fook-Thean Lee, Aurora Poon, Nicole Potasz, W. Hopkins, Geoffrey Chong, Fiona E Smyth, Jonathan Cebon, Antony W. Burgess, Lloyd J. Old, Veronika Wirth, Paul Schleyer, Angela Mountain, Roger Murphy, Andrew M. Scott, Anthony T. Papenfuss, … Ian D. Davis. (2005). Phase I Trial of 131I-huA33 in Patients with Advanced Colorectal Carcinoma. Clinical Cancer Research, 11, 4818–4826.

Chicago

Graeme O’Keefe, Niall C. Tebbutt, T. Saunder, Bridget Chappell, Fook-Thean Lee, Aurora Poon, Nicole Potasz, et al. 2005. “Phase I Trial of 131I-HuA33 in Patients with Advanced Colorectal Carcinoma.” Clinical Cancer Research 11 (July): 4818–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....279d631fcd4731315833a01d22277f48&authtype=sso&custid=ns315887.